Medicines for Malaria Venture

The Medicines for Malaria Venture (MMV) was established in 1999 to build and manage a research and development portfolio capable of leading to the registration of at least one new antimalarial drug every five years.

Although partnered with industry, MMV's focus is on discovery and development of drugs that will be affordable to populations living in malaria endemic areas.

MMV manages and directs research and development activities carried out at a broad variety of institutions, comprising 42 academic and pharmaceutical organizations located in 10 different countries.

At present, there are 38 candidate anti-malarial agents in MMV's portfolio, including several completely new therapeutic targets.

This portfolio is highly dynamic and managed to accelerate the identification and development of promising candidates and also the recognition and rapid replacement of less promising drug projects.